- Home
- TCBX vs KMDA Comparison
TCBX vs KMDA Comparison
Compare TCBX & KMDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TCBX
- KMDA
- Stock Information
- Founded
- TCBX 2008
- KMDA 1990
- Country
- TCBX United States
- KMDA Israel
- Employees
- TCBX N/A
- KMDA N/A
- Industry
- TCBX Banks
- KMDA Biotechnology: Pharmaceutical Preparations
- Sector
- TCBX Finance
- KMDA Health Care
- Exchange
- TCBX Nasdaq
- KMDA Nasdaq
- Market Cap
- TCBX 454.9M
- KMDA 399.7M
- IPO Year
- TCBX 2021
- KMDA N/A
- Fundamental
- Price
- TCBX $35.42
- KMDA $7.77
- Analyst Decision
- TCBX Hold
- KMDA Strong Buy
- Analyst Count
- TCBX 4
- KMDA 2
- Target Price
- TCBX $33.67
- KMDA $13.00
- AVG Volume (30 Days)
- TCBX 66.5K
- KMDA 78.9K
- Earning Date
- TCBX 07-23-2025
- KMDA 08-13-2025
- Dividend Yield
- TCBX N/A
- KMDA 2.58%
- EPS Growth
- TCBX 44.43
- KMDA 31.21
- EPS
- TCBX 2.95
- KMDA 0.28
- Revenue
- TCBX $172,270,000.00
- KMDA $167,235,000.00
- Revenue This Year
- TCBX $17.44
- KMDA $14.51
- Revenue Next Year
- TCBX $6.46
- KMDA $9.31
- P/E Ratio
- TCBX $12.01
- KMDA $28.07
- Revenue Growth
- TCBX 17.40
- KMDA 11.83
- 52 Week Low
- TCBX $20.15
- KMDA $5.08
- 52 Week High
- TCBX $39.45
- KMDA $9.16
- Technical
- Relative Strength Index (RSI)
- TCBX 69.59
- KMDA 69.39
- Support Level
- TCBX $34.36
- KMDA $7.62
- Resistance Level
- TCBX $35.66
- KMDA $7.92
- Average True Range (ATR)
- TCBX 1.07
- KMDA 0.21
- MACD
- TCBX 0.27
- KMDA 0.01
- Stochastic Oscillator
- TCBX 95.54
- KMDA 83.18
About TCBX Third Coast Bancshares Inc.
Third Coast Bancshares Inc is a bank holding company. It focuses on providing commercial banking solutions to small and medium-sized businesses and professionals with operations in its markets. The bank operates eleven branches in the Greater Houston, Dallas-Fort Worth, and Austin-San Antonio markets, and one branch in Detroit, Texas. The company operates through one segment, community banking, It generates the majority of its revenue from interest on loans, customer service, and loan fees.
About KMDA Kamada Ltd.
Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, the Proprietary Products segment and the Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.